Cargando…
Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients
We investigated whether circulating microparticles (MPs) could serve as prognostic biomarkers in non-small cell lung cancer (NSCLC) patients. We enrolled 25 control subjects and 136 NSCLC patients categorized into disease-progression (DP, n=42) and disease-control (DC, n=94) groups. Flow cytometric...
Autores principales: | Wang, Chin-Chou, Tseng, Chia-Cheng, Chang, Huang-Chih, Huang, Kuo-Tung, Fang, Wen-Feng, Chen, Yu-Mu, Yang, Cheng-Ta, Hsiao, Chang-Chun, Lin, Meng-Chih, Ho, Chi-Kung, Yip, Hon-Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652677/ https://www.ncbi.nlm.nih.gov/pubmed/29100283 http://dx.doi.org/10.18632/oncotarget.18372 |
Ejemplares similares
-
Levels of Circulating Microparticles in Lung Cancer Patients and Possible Prognostic Value
por: Tseng, Chia-Cheng, et al.
Publicado: (2013) -
Circulating Endothelial-Derived Activated Microparticle: A Useful Biomarker for Predicting One-Year Mortality in Patients with Advanced Non-Small Cell Lung Cancer
por: Wang, Chin-Chou, et al.
Publicado: (2014) -
Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2015) -
Comparing survival and treatment response of patients with acquired T790M mutation second‐line osimertinib versus sequential treatment of chemotherapy followed by osimertinib: A real‐world study
por: Wang, Chin‐Chou, et al.
Publicado: (2021) -
The Influence of Obesity on Different Genders in Patients with Obstructive Sleep Apnea
por: Huang, Kuo-Tung, et al.
Publicado: (2014)